{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:21:29Z","timestamp":1791958889044,"version":"4.3.4"},"reference-count":12,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2010,10,29]],"date-time":"2010-10-29T00:00:00Z","timestamp":1288310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bipolar Disorders"],"published-print":{"date-parts":[[2010,11]]},"abstract":"<jats:p>Baldessarini RJ. Commentary: The Bipolar Affective Disorder: Lithium\/Anticonvulsant Evaluation (BALANCE) Study.\u2028Bipolar Disord 2010: 12: 669\u2013672. \u00a9 2010 The Author.\u2028Journal compilation \u00a9 2010 John Wiley &amp; Sons A\/S.<\/jats:p>","DOI":"10.1111\/j.1399-5618.2010.00860.x","type":"journal-article","created":{"date-parts":[[2010,10,29]],"date-time":"2010-10-29T12:59:28Z","timestamp":1288357168000},"page":"669-672","source":"Crossref","is-referenced-by-count":4,"title":["Commentary: The Bipolar Affective Disorder: Lithium\/Anticonvulsant Evaluation (BALANCE) Study"],"prefix":"10.1111","volume":"12","author":[{"given":"Ross J","family":"Baldessarini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,10,29]]},"reference":[{"key":"e_1_2_3_2_2","first-page":"429","volume-title":"Goodman and Gilman\u2019s The Pharmacological Basis of Therapeutics","author":"Baldessarini RJ","year":"2005"},{"key":"e_1_2_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.02.034"},{"key":"e_1_2_3_4_2","doi-asserted-by":"publisher","DOI":"10.3310\/hta11390"},{"key":"e_1_2_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(99)00196-2"},{"key":"e_1_2_3_6_2","doi-asserted-by":"publisher","DOI":"10.3109\/9780203007051"},{"key":"e_1_2_3_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3181c9fdd3"},{"key":"e_1_2_3_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/hup.1095"},{"key":"e_1_2_3_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2008.00550.x"},{"key":"e_1_2_3_10_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1103291"},{"key":"e_1_2_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61828-6"},{"key":"e_1_2_3_12_2","doi-asserted-by":"publisher","DOI":"10.3109\/10673221003747955"},{"key":"e_1_2_3_13_2","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1176\/ps.2008.59.10.1175","article-title":"Use of psychotropic medicines in bipolar disorder patients in the United States","volume":"59","author":"Baldessarini RJ","year":"2008","journal-title":"Psychiatr Serv"}],"container-title":["Bipolar Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-5618.2010.00860.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-5618.2010.00860.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T06:45:09Z","timestamp":1698734709000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-5618.2010.00860.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,29]]},"references-count":12,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["10.1111\/j.1399-5618.2010.00860.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-5618.2010.00860.x","archive":["Portico"],"relation":{},"ISSN":["1398-5647","1399-5618"],"issn-type":[{"value":"1398-5647","type":"print"},{"value":"1399-5618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,29]]}}}